Home › Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals
 

Keywords :   


Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals

2013-09-04 06:25:07| drugdiscoveryonline News Articles

Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced recently the US FDA acceptance of the IND filing for a novel molecule targeting prostate cancer with Endo Pharmaceuticals of the US

Tags: successful drug filing announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.09Atlantic Tropical Weather Outlook
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
22.09Eastern North Pacific Tropical Weather Outlook
22.09Amazon says workers must be in the office. The UK government disagrees. Who is right?
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
More »